ABcann Global Executive Team Highlights Recreational and Pharmaceutical Focus -- CFN Media
Dec 04, 2017 14:01 pm UTC| Business
SEATTLE, WA, Dec. 04, 2017 -- CFN Media Group ("CannabisFN"), the leading creative agency and media network dedicated to legal cannabis, announces publication of an article covering recent ABcann Global Corp. (TSX-V:...
RADA Radar Selected to Support Industrial UAS Operations
Dec 04, 2017 14:01 pm UTC| Business
NETANYA, Israel, Dec. 04, 2017 -- RADA Electronic Industries Ltd. (Nasdaq:RADA) announced today that its extended version of its Multi-mission Hemispheric Radar - ieMHR, has been selected by a leading global defense...
Uptick Newswire “Stock Day” Interviews BLDV CEO on the Medical Cannabis Industry
Dec 04, 2017 14:01 pm UTC| Business
Phoenix, AZ, Dec. 04, 2017 -- Uptick Newswire is the sole producer of the Uptick Network “Stock Day” Podcast keeping investors and shareholders up to date on company news and bringing transparency to the micro-cap...
Dec 04, 2017 14:01 pm UTC| Business
SAN FRANCISCO, Dec. 04, 2017 -- The letter of intent signed to develop this oil gas company's large acreage in the red-hot Permian Basin would not only eliminate the company's capex budget, it could give the company a...
ForgeRock Extends Trust Network, Adds New Technology Partner Program
Dec 04, 2017 14:01 pm UTC| Business
SAN FRANCISCO, Dec. 04, 2017 -- ForgeRock®, a leading platform provider of digital identity management solutions, today announced an extension of the ForgeRock Trust Network partner program designed to unify its...
GreenPower Receives Order for L.A. Unified’s First Electric School Bus
Dec 04, 2017 14:01 pm UTC| Business
PORTERVILLE, Calif., Dec. 04, 2017 -- GreenPower Motor Company Inc. (TSX-V:GPV) (OTCQX:GPVRF) (“GreenPower”) has received a purchase order and the initial deposit for its Synapse 72 all-electric school bus for the Los...
Dec 04, 2017 14:01 pm UTC| Business
SAN DIEGO, Dec. 04, 2017 -- La Jolla Pharmaceutical Company (NASDAQ:LJPC) (the Company or La Jolla) today announced the initiation of a pivotal clinical study of LJPC‑401 (synthetic human hepcidin) in patients with...